GlaxoSmithKline's total assets for Q1 2026 were £62.87B, an increase of 2.86% from the previous quarter. GB:GSK total liabilities were £45.45B for the fiscal quarter, a 0.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.